A study of these molecules in animal models showed that the use of these inhibitors resulted in the enrichment of the tumor with cells with high PD-L1 expression, indicating the need for simultaneous use of c-Myc and PD-1 inhibitors [282]. This evidence concerns the gene CD274 and neoplasm.